Binary Measures for Associating Medication Adherence and Healthcare Spending
The use of an 80% threshold or other binary cut point may be insufficient for characterizing the relationship between medication adherence and Medicare spending.
Racial Variation in the Cost-effectiveness of Chemotherapy for Prostate Cancer
The likelihood of chemotherapy being cost-effective for patients with metastatic prostate cancer differs across racial subgroups. This uncertainty presents challenges for managed-care decision makers.
Healthcare Utilization and Cost Effects of Prior Authorization for Pregabalin in Commercial Health Plans
Prior authorization for pregabalin in commercial insurance plans accomplished the objective of lower pregabalin utilization; however, there was no significant decrease in disease-related healthcare costs.
Effects of a Medicaid Prior Authorization Policy for Pregabalin
State Medicaid programs’ pregabalin prior authorization accomplished the objective of lower pregabalin utilization; the unintended effects were increased opioid use and increased disease-related healthcare costs.
